Clinical trial for Epilepsy
Official title Diagnosing Epilepsy To EffeCT Change
ClinicalTrials.gov ID: NCT07110337
What this study is testing
- What it's testing
- The study compares the Minder System to usual care to see if it gives reliable seizure data for patients whose seizures are not well captured by standard EEG tests.
- Who it's for
- Adults with epilepsy whose seizures are not well detected by standard EEG and who cannot use other monitoring methods.
- What's involved
- Participants either get the Minder device implanted under the scalp or continue with standard care. Those with the device may or may not have their doctors see the data, and all participants have regular visits and assessments.
- Time commitment
- The study lasts up to 6 months, with follow‑up visits until a treatment plan is decided or the 6‑month visit is reached.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Diagnosis of focal and/or generalized epilepsy.
- Drug-resistant
- At least an average of 1 seizure within the past 3 months
- Participant completed a multi-day EEG assessment that was inconclusive, and is unchanged since the last EEG monitoring.
You likely can't join if
- Epilepsy surgery within the past 6 months
- Active Deep Brain Stimulation (DBS) or Responsive Neurostimulator System (RNS)
- Participant needs treatments or assessments that are not indicated with the Minder System like Magnetic Resonance Imaging (MRI), Electro-Convulsive...
- Participant cannot have surgery to have the device implanted
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Irvine, California, United States
- Palo Alto, California, United States
- San Diego, California, United States
- New Haven, Connecticut, United States
- Jacksonville, Florida, United States
- Miami, Florida, United States
- Tampa, Florida, United States
- Indianapolis, Indiana, United States
- Boston, Massachusetts, United States
- Ann Arbor, Michigan, United States
- Minneapolis, Minnesota, United States
- Rochester, Minnesota, United States
- St Louis, Missouri, United States
- Billings, Montana, United States
- Charlotte, North Carolina, United States
- Durham, North Carolina, United States
- Clevland, Ohio, United States
- Philadelphia, Pennsylvania, United States
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Phoenix, Arizona, United States; Irvine, California, United States; Palo Alto, California, United States; San Diego, California, United States; New Haven, Connecticut, United States and 16 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.